Congratulations to Daphne Lainson, France Leclaire and David St-Martin for their inclusion in the 2025 edition of IAM Strategy 300: The World’s Leading IP Strategists. Each year, IAM Strategy 300 recognizes those who innovatively create and action strategies which realize and amplify the worth of IP portfolios.
Daphne Lainson provides strategic advice and counselling to clients across the life cycle of a drug, including during pre-clinical and clinical development through to marketing and loss of exclusivity. She is dedicated to helping innovators secure comprehensive patent protection for their chemical, pharmaceutical and biotechnology-related inventions.
France Leclaire specializes in the life sciences sector with a focus on prosecution, client counselling, and patent portfolio growth and utilization. As a leader in her field, France regularly advises clients on biotechnology related innovations, turning their inventions into market value.
David St-Martin's practice includes drafting and prosecuting patent applications in the fields of material science, metallic powders manufacturing processes, pharmaceuticals, organic and inorganic chemistry, cosmetics, mining processes and products, green technologies, gas fermentation processes, nanotechnology and plasma torch related technologies.
View the full 2025 list of IAM Strategy 300: The World’s Leading IP Strategists online.